Oct 07, 2025
3 min read
UNIQURE N.V. recently announced the results of a positive higher line of important study for the first/second stage in relation to the AMT-130 for Huntington, as it achieved the preliminary end point that was previously identified and shows a statistically slow development of the disease in patients with a high dose for three years compared to external control. This achievement is accompanied by the success of an advanced shares offer of $ 300 million and a new loan for future decades of $ 175 million, which puts the company to pay the regulations ...
- whether
Why Uniquure (Qure) is after a strong AMT-130 data and $ 475 million in new funds
He rated Sasha Jovanovic
- unively announced the best result from alive n.v.tut alt-130
-The milestone was a successful $ 300 million subsequent equity offerings and a new US Dollar Term loan, giving the company an attitude to promote regulatory submission efforts and prepare the county-130's potential commercialization.
- I am hoping for the future, promises and future hopes.
Holds giants: these 25 and the actions at an early stage can finance their retirement.
Unique Investment Narrative Review
FDA-130 and AMT-130, AMT-130, AMT-130, AMT-130) in FDA's owners to become a shareholders in Federal Curve.Roses, but may not be delayed or the risk of disciplinary and product risks that can be affected by future income.
The $ 300 million $ 300 million tracking offer in September 2025 is particularly relevant, making sure that Uniquure is capable, as well as advancement to advance regulatory references and to prepare for a potential launch of the product.This increased financial position also helps reduce the short -term and sale -free financing risk,
However, investors should also be careful that despite the recent progress, there are still significant risks on regulatory results and ...
Read the full verbal statement (it's free!)
The University forecast of the University forecast of $ 32.3 million was $ 32.3 million in 2028 years and currently currently 157.6 million soums.USD is $ 217.6 million.USD.
Open in unique conservations as they make the appropriate amount of $ 66.50, 21% looking at its current price.
Study of others
Simply considering the Wall Steeus in Simple Street, looking at any partner $ 13.55 and $ 13.5 and $ 448.06 $.Another key exam is the approval process, which can create prospects for the coming years.
Explore 6 other estimates of fair value on Unique - why the stock can be worth over 8x more than the current price!
Create your own illustration
Do not agree with the existing narrative?
- Our analysis for your unquare research is our analysis - 2 basic prizes and 3 important warning signs that may affect your investment decision.
Our free Unique Research report provides a snowflake, a snowflake, which is a snowflake, which provides a comprehensive basic analysis that makes it easier to evaluate the unique.
Looking for a new view?
Don't miss the next 10th-day shot.The settings of the nearby promotion have fallen only:
- Check the largest penny share that equals the risk and gifts.
- This technology can replace the computer: Find a 26 section that works to feel the Kwantum Computing.
- We have discovered 19 US shares that are expected to pay more than 6 % of the next year.Check out the entire list for free.
This article by Simply Wall St is of a general nature.It assumed the latest ads of the sensitive or qualitative materials of the company's prices.The only wall has no position in any aforementioned action.
Evaluation is difficult, but we are here to simplify it.
Find out if UNIQUR may be worthless or more than Value by our proper analysis of our value, potential, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, dividends, and financial status of our financial dividends, dividends and financial status.
Disagree in this article?Has the content worried you?In addition to you
They are raised in treatment to rarely suffering patients and other stressing diseases in the United States.
Great potential growth with a minor risk.
